Related Experiment Video
Updated: May 19, 2026

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
Published on: July 21, 2017
Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence
C Drullion1, C Trégoat, V Lagarde
1Laboratoire hématopoïèse leucémique et cibles thérapeutiques, INSERM U1035, Université Bordeaux Ségalen, 33076 Bordeaux, cedex, France.
Abstract:
Imatinib, the anti-Abl tyrosine kinase inhibitor used as first-line therapy in chronic myeloid leukemia (CML), eliminates CML cells mainly by apoptosis and induces autophagy. Analysis of imatinib-treated K562 cells reveals a cell population with cell cycle arrest, p27 increase and senescence-associated beta galactosidase (SA-β-Gal) staining. Preventing apoptosis by caspase inhibition decreases annexin V-positive cells, caspase-3 cleavage and increases the SA-β-Gal-positive cell population. In addition, a concomitant increase of the cell cycle inhibitors p21 and p27 is detected emphasizing the senescent phenotype. Inhibition of apoptosis by targeting Bim expression or overexpression of Bcl2 potentiates senescence. The inhibition of autophagy by silencing the expression of the proteins ATG7 or Beclin-1 prevents the increase of SA-β-Gal staining in response to imatinib plus Z-Vad. In contrast, in apoptotic-deficient cells (Bim expression or overexpression of Bcl2), the inhibition of autophagy did not significantly modify the SA-β-Gal-positive cell population. Surprisingly, targeting autophagy by inhibiting ATG5 is accompanied by a strong SA-β-Gal staining, suggesting a specific inhibitory role on senescence. These results demonstrate that in addition to apoptosis and autophagy, imatinib induced senescence in K562 CML cells. Moreover, apoptosis is limiting the senescent response to imatinib, whereas autophagy seems to have an opposite role.
Insights
Imatinib therapy for chronic myeloid leukemia (CML) induces cell death via apoptosis and autophagy, but also triggers senescence. Apoptosis limits senescence, while autophagy appears to promote it.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Imatinib is a first-line therapy for chronic myeloid leukemia (CML).
- Imatinib eliminates CML cells through apoptosis and autophagy.
- The role of senescence in imatinib's mechanism of action is not fully understood.
Purpose of the Study:
- To investigate the induction of senescence by imatinib in K562 CML cells.
- To elucidate the interplay between apoptosis, autophagy, and senescence in response to imatinib.
Main Methods:
- Analysis of imatinib-treated K562 cells for cell cycle arrest, p27 expression, and SA-β-Gal staining.
- Modulation of apoptosis (caspase inhibition, Bim targeting, Bcl2 overexpression) and autophagy (ATG7, Beclin-1, ATG5 silencing).
Main Results:
- Imatinib induces cell cycle arrest, p27 increase, and SA-β-Gal staining, indicative of senescence.
- Inhibition of apoptosis potentiates imatinib-induced senescence.
- Autophagy inhibition (ATG7, Beclin-1) reduces senescence, while ATG5 inhibition enhances it, suggesting a complex role.
Conclusions:
- Imatinib induces senescence in CML cells, alongside apoptosis and autophagy.
- Apoptosis acts as a limiting factor for imatinib-induced senescence.
- Autophagy plays a complex, potentially opposing role in imatinib-induced senescence.
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
12:44Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
Published on: October 11, 2012
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
Apoptosis
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Extrinsic Apoptotic Pathway